Trexquant Investment’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Trexquant Investment’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-13,486	Closed	-$256K	–	1321
2019 Q1	$256K	Buy	13,486 +2,754	+26%	+$44.7K	0.02%	802
2018 Q4	$145K	Buy	+10,732	New	+$120K	0.01%	959
2015 Q4	–	Sell	-10,600	Closed	-$195K	–	1476
2015 Q3	$195K	Buy	+10,600	New	+$205K	0.02%	978

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Trexquant Investment's OSIR Position: Q2 2019 in Review

Trexquant Investment sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 13,486 shares — an estimated $256K sold.

Trexquant Investment first reported a position in OSIR in Q3 2015 and held it in 3 quarters. The position peaked at $256K in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Trexquant Investment reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Trexquant Investment sold 13,486 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $256K.
Trexquant Investment first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 3 quarters.
Trexquant Investment's Osiris Therapeutics, Inc. Common Stock position peaked at $256K in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Trexquant Investment's 13F filing for Q2 2019, filed 9 Aug 2019.